Article Text

Download PDFPDF
Contraception: satisfaction with the method, effects on sleep and psychological well-being
  1. Elena Toffol1,2,
  2. Timo Partonen1,
  3. Oskari Heikinheimo3,
  4. Satu P Suhonen4
  1. 1 Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland
  2. 2 Department of Psychology and Logopedics, University of Helsinki, Helsinki, Finland
  3. 3 Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
  4. 4 Centralized Family Planning, Department of Social Services and Health Care, Helsinki, Finland
  1. Correspondence to Dr Elena Toffol, Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, 00271, Finland; elena.toffol{at}

Statistics from

Mood changes during use of contraception are often reported as side effects and reasons for dissatisfaction and discontinuation of use. Recent register-based studies show associations between contraceptive use and risk of depression and attempted suicide, especially in adolescents and during the first months of use.1 2 We prospectively assessed the relationships between use of contraception, satisfaction with the method, sleep-related symptoms and psychological well-being.

Within the services offered by the City of Helsinki, all women planning or using subdermal contraceptive implants, all nulliparous women planning intrauterine contraception, or women with contraceptive problems are referred to a Centralized Family Planning Clinic. Our study included 182 women of at least 18 years of age attending this clinic. More than a third of them (37.4%) were planning either to change or to discontinue their contraceptive method. Of the remainder, 52 (28.6%) were starting contraception, and 62 (34%) were attending a follow-up visit and continuing with their present method. We divided the participants into three groups: starters, continuers and …

View Full Text


  • Contributors All authors contributed to the study conception and design. SS contributed to data acquisition, ET performed statistical analyses, and SS and ET were major contributors in writing the manuscript. All authors contributed to interpreting the results, and reviewing and editing the manuscript. All authors read and approved the final manuscript.

  • Funding Funding for this study was provided in part by the National Graduate School for Clinical Investigation, the Finnish Cultural Foundation, the Jalmari and Rauha Ahokas Foundation and Helsinki University Hospital EVO grants (ET).

  • Competing interests OH serves occasionally on advisory boards for Bayer Healthcare, Gedeon Richter and MSD Finland (part of Merck & Co. Inc.) and has designed educational events with these companies. SS has been a consultant for Gedeon Richter and Exeltis and lectured at educational events of Bayer Healthcare and Sandoz Finland (part of Novartis Dimension).

  • Patient consent Not required.

  • Ethics approval The study was approved by the ethics committee of the City of Helsinki Health Centre.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.